Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
14.43
-0.36 (-2.43%)
Jun 27, 2025, 4:00 PM - Market closed
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $208.89 million as of June 27, 2025. Its market cap has decreased by -18.60% in one year.
Market Cap
208.89M
Enterprise Value
98.90M
1-Year Change
-18.60%
Ranking
Category
Stock Price
$14.43
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $208.89M, an increase of 5.37%. That is a compound annual growth rate of 5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 220.18M | -1.23% |
| Dec 31, 2024 | 222.93M | 12.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.10B |
| Johnson & Johnson | 366.71B |
| AbbVie | 324.15B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 279.88B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.14B |
| AstraZeneca | 215.99B |